Opdivo (nivolumab) - BMS
ANV419 - Anaveon
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/38702147
 
Aurélien Marabelle; David Combarel; François-Xavier Danlos; Julia Delahousse; Justin Cagnat; Kaïssa Ouali; Laurent Mathiot; Santiago Ponce; Sophie Broutin; Stéphane Champiat; Yohann Loriot
 
May 4, 2024
 
Next